Healthy Skepticism Library item: 5533

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

MaLAM Letter follow up—antidiarrhoeals
MaLAM International Newsletter 1993 Feb

Abstract:

MaLAM has written to Farmitalia Carlo Erba, Parke-Davis and Wyeth about the marketing of different drugs for diarrhea. Farmitalia Carlo Erba has not responded to MaLAM, Parke-Davis will replace the combination product paromomycin + kaolin + pectin with one containing just paromomycin but has not provided any evidence for the use of paromomycin. Wyeth announced that all of the companies antidiarrheals are being withdrawn.

Keywords:
*news story/developing countries/Farmitalia Carlo Erba/Parke-Davis/Wyeth/diarrhea/company responses/MaLAM/Medical Lobby for Appropriate Marketing/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: DIARRHEA/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES